Trinity Biotech plc (TRIB) Reports In-Line Q3 EPS

Trinity Biotech plc (NASDAQ: TRIB) reported Q3 EPS of $0.20, in-line with the analyst estimate of $0.20. Revenue for the quarter came in at $20.9 million versus the consensus estimate of $21.96 million.

For earnings history and earnings-related data on Trinity Biotech plc (TRIB) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c